Drugs Starting with N
BioSniper tracks 70 drugs and molecules whose names begin with N — each linked to its developers, clinical trials, indications, and FDA decisions. Data availability reflects the latest successfully ingested source records; source and as-of dates are shown where available.
Browse A–ZN
- nabiximols1
- nadofaragene firadenovec
- nalbuphine
- naldemedine
- nalmefene
- naloxone1
- naltrexone1
- naltrexone hydrochloride; oxycodone2
- namzaric2
- naphazoline
- naporafenib1
- naproxen
- narsoplimab
- natalizumab
- navenibart2
- navepegritide1
- navicixizumab2
- navitoclax
- naxitamab
- nbtxr31
- nc5251
- ndv-01
- nebivolol2
- necitumumab1
- nedosiran1
- neffy
- neflamapimod
- nelarabine2
- nelitolimod1
- nemvaleukin alfa1
- neo100
- neo2121
- neomycin
- nerandomilast
- neratinib1
- nereus1
- nexobrid2
- ngenla3
- ngm1201
- niacin
- niclosamide
- nicotine
- nifedipine
- nilotinib2
- nilutamide1
- nimacimab1
- nintedanib3
- nipocalimab1
- niraparib
- nirogacestat
- nirsevimab
- nisevokitug
- nitazoxanide1
- nitroglycerin2
- nivolumab1
- nkg2d-fc fusion protein qeq278
- nktr-2551
- nkx0191
- nlrp3 inhibitor dfv890
- nogapendekin alfa inbakicept2
- nomlabofusp
- nt-175
- nuc-3373
- nuc-7738
- numidargistat1
- nusinersen1
- nuzefatide pevedotin2
- nvx-cov2373
- nxp8001
- nxp9001
From drug list to evidence case
Define what these drug programs must prove
Choose the developer, phase, trial, indication, and FDA evidence that should count in your drug thesis.